Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 5/20 | 0.56 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | EGFR | P00533 | 1/20 | 0.56 |
| ▸ | LCK | P06239 | 1/20 | 0.56 |
| ▸ | FYN | P06241 | 1/20 | 0.56 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | HTR2A | P28223 | 1/20 | 0.56 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.56 |
| ▸ | RECQL | P46063 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.56 |
| ▸ | PTPRC | P08575 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17693637 | 1.00 | SLC7A5 (0.56) | SLC7A5PTGS1KDM4EUSP2EGFR | |
| SCHEMBL17693595 | 0.90 | ALOX15 (0.43) | SLC7A5PTGS1KDM4EUSP2EGFR | |
| SCHEMBL17693640 | 0.90 | SLC7A5 (0.56) | SLC7A5PTGS1KDM4EUSP2EGFR | |
| SCHEMBL21574914 | 0.90 | SLC7A5 (0.56) | SLC7A5PTGS1KDM4EUSP2EGFR | |
| SCHEMBL17685909 | 0.87 | ALDH1A1 (0.46) | SLC7A5PTGS1KDM4EUSP2EGFR | |
| SCHEMBL17685908 | 0.87 | ALDH1A1 (0.46) | SLC7A5PTGS1KDM4EUSP2EGFR | |
| SCHEMBL9108309 | 0.84 | SLC7A5 (0.61) | SLC7A5PTGS1KDM4EUSP2EGFR | |
| SCHEMBL28441906 | 0.84 | SLC7A5 (0.61) | SLC7A5PTGS1KDM4EUSP2EGFR | |
| SCHEMBL28440219 | 0.84 | SLC7A5 (0.49) | SLC7A5PTGS1KDM4EUSP2EGFR | |
| SCHEMBL20921829 | 0.81 | SLC7A5 (0.57) | SLC7A5PTGS1KDM4EUSP2EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111494395-B | Carbidopa and levodopa prodrugs and their use for treating parkinson's disease | 艾伯维公司 | 2024-06-21 | — | — | CN | disclosed |
| EP-4186510-A1 | INTERMEDIATES AND PROCESS FOR PREPARING L-DOPA DIPHOSPHATE | AbbVie Inc. (US) | 2023-05-31 | — | — | EP | disclosed |
| CN-111454290-B | Carbidopa and levodopa prodrugs and their use for treating parkinson's disease | 艾伯维公司 | 2022-12-23 | — | — | CN | disclosed |
| CN-111362980-B | Carbidopa and levodopa prodrugs and their use for treating parkinson's disease | 艾伯维公司 | 2022-10-18 | — | — | CN | disclosed |
| CN-111494395-A | Carbidopa and levodopa prodrugs and their use for treating parkinson's disease | 艾伯维公司 | 2020-08-07 | — | — | CN | disclosed |
| CN-111454290-A | Carbidopa and levodopa prodrugs and their use for treating parkinson's disease | 艾伯维公司 | 2020-07-28 | — | — | CN | disclosed |
| CN-111362980-A | Carbidopa and levodopa prodrugs and their use for treating parkinson's disease | 艾伯维公司 | 2020-07-03 | — | — | CN | disclosed |
| EP-3569587-A1 | INTERMEDIATES AND PROCESS FOR PREPARING L-DOPA DIPHOSPHATE | AbbVie Inc. (US) | 2019-11-20 | — | — | EP | disclosed |
| EP-3209302-B1 | CARBIDOPA AND L-DOPA PRODRUGS AND THEIR USE TO TREAT PARKINSON'S DISEASE | ABBVIE INC (US) | 2019-04-24 | — | — | EP | disclosed |